JP2024531765A5 - - Google Patents
Info
- Publication number
- JP2024531765A5 JP2024531765A5 JP2024516808A JP2024516808A JP2024531765A5 JP 2024531765 A5 JP2024531765 A5 JP 2024531765A5 JP 2024516808 A JP2024516808 A JP 2024516808A JP 2024516808 A JP2024516808 A JP 2024516808A JP 2024531765 A5 JP2024531765 A5 JP 2024531765A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- tumor
- gefitinib
- tamoxifen
- vinorelbine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163244412P | 2021-09-15 | 2021-09-15 | |
| US63/244,412 | 2021-09-15 | ||
| PCT/US2022/043601 WO2023043883A1 (en) | 2021-09-15 | 2022-09-15 | Triple-agent therapy for cancer treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024531765A JP2024531765A (ja) | 2024-08-29 |
| JP2024531765A5 true JP2024531765A5 (https=) | 2025-09-25 |
Family
ID=85603487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024516808A Pending JP2024531765A (ja) | 2021-09-15 | 2022-09-15 | がん治療のための三剤療法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12611411B2 (https=) |
| EP (1) | EP4401720A4 (https=) |
| JP (1) | JP2024531765A (https=) |
| KR (1) | KR20240060625A (https=) |
| CN (1) | CN118159262A (https=) |
| AU (1) | AU2022345084A1 (https=) |
| CA (1) | CA3231639A1 (https=) |
| IL (1) | IL311229A (https=) |
| MX (1) | MX2024003333A (https=) |
| WO (1) | WO2023043883A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2644194T3 (en) * | 2008-03-18 | 2017-07-03 | Genentech Inc | Combinations of an anti-HER2 antibody-drug conjugate and docetaxel |
| US20100189683A1 (en) | 2008-11-14 | 2010-07-29 | Ascenta Therapeutics, Inc. | Pulsatile Dosing of Gossypol for Treatment of Disease |
| KR101874390B1 (ko) * | 2013-09-26 | 2018-07-04 | 파이브3 제노믹스, 엘엘씨 | 바이러스-연관 종양을 위한 시스템, 방법, 및 조성물 |
-
2022
- 2022-09-15 MX MX2024003333A patent/MX2024003333A/es unknown
- 2022-09-15 US US18/689,980 patent/US12611411B2/en active Active
- 2022-09-15 WO PCT/US2022/043601 patent/WO2023043883A1/en not_active Ceased
- 2022-09-15 EP EP22870665.1A patent/EP4401720A4/en active Pending
- 2022-09-15 CN CN202280069063.5A patent/CN118159262A/zh active Pending
- 2022-09-15 IL IL311229A patent/IL311229A/en unknown
- 2022-09-15 KR KR1020247010862A patent/KR20240060625A/ko active Pending
- 2022-09-15 JP JP2024516808A patent/JP2024531765A/ja active Pending
- 2022-09-15 CA CA3231639A patent/CA3231639A1/en active Pending
- 2022-09-15 AU AU2022345084A patent/AU2022345084A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7216829B2 (ja) | Ｘｅｌｏｘ又はｆｏｌｆｏｘと組み合わせたｔｔフィールドを用いる胃癌の治療 | |
| JP7278331B2 (ja) | がんの処置において使用するための、Ｎｏｔｃｈ阻害剤およびＰＩ３Ｋ／ｍＴＯＲ阻害剤を用いた併用療法 | |
| US20230072294A1 (en) | Compositions, methods, systems and/or kits for preventing and/or treating neoplasms | |
| KR102615210B1 (ko) | 난소암의 치료에 사용되는 티노스타무스틴 | |
| AU2015360095A1 (en) | Quinoline derivative against non-small cell lung cancer | |
| ES2904365T3 (es) | Administración conjunta de esteroides y ácido zoledrónico para prevenir y tratar la osteoartritis | |
| JP2018177808A (ja) | 抗癌療法 | |
| CA3080644A1 (en) | Use of parp inhibitor in treating chemotherapy-resistant ovarian cancer or breast cancer | |
| EP3027191A1 (en) | Combinations of a btk inhibitor and fluorouracil for treating cancers | |
| TW202120096A (zh) | 使用包含atp競爭性akt抑制劑、cdk4/6抑制劑及氟維司群之組合療法治療乳癌 | |
| AU2018285822A1 (en) | Tinostamustine for use in treating sarcoma | |
| CN102056609B (zh) | 药物组合 | |
| CN114831988A (zh) | 治疗非小细胞肺癌的喹啉衍生物 | |
| JP2019501185A (ja) | 食道癌を治療するためのキノリン誘導体の使用とその治療方法、医薬組成物及びキット | |
| TW201313228A (zh) | Ｎ－羥基－４－｛２－［３－（ｎ，ｎ－二甲基胺基甲基）苯並呋喃－２－基羰基胺基］乙氧基｝苯甲醯胺之新穎投藥法 | |
| US20130331368A1 (en) | Method of treating hepatocellular carcinoma | |
| US20090196871A1 (en) | Use of 4-pyridylmethylphthalazines for cancer treatment | |
| CN111728974B (zh) | 西奥罗尼用于小细胞肺癌的治疗 | |
| Fantini et al. | Toxic encephalopathy in elderly patients during treatment with capecitabine: literature review and a case report | |
| JP2024531765A5 (https=) | ||
| Hsieh et al. | Cisplatin, tegafur-uracil and leucovorin plus mitomycin C: an acceptably effective and toxic regimen for patients with recurrent or metastatic nasopharyngeal carcinoma | |
| RU2678103C2 (ru) | Противоопухолевое средство, содержащее противоопухолевый комплекс платины, и усилитель противоопухолевого эффекта | |
| CN102883720A (zh) | 治疗胰腺癌的方法 | |
| AU2002342678A1 (en) | Use of 4-pyridylmethylphthalazines for cancer treatment | |
| Koukourakis et al. | Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy |